Melanoma Research Alliance on LinkedIn: MRA Statement on Expanded Approval of Nivolumab to Patients with Stage 2…
![CURE(R) Teams up with Melanoma Research Foundation and AIM at Melanoma to Collaborate in Advocacy Spotlight Partnership Program | Princeton, NJ Patch CURE(R) Teams up with Melanoma Research Foundation and AIM at Melanoma to Collaborate in Advocacy Spotlight Partnership Program | Princeton, NJ Patch](https://patch.com/img/cdn/users/1993020/stock/raw/20150655709b4b7cf2b.png)
CURE(R) Teams up with Melanoma Research Foundation and AIM at Melanoma to Collaborate in Advocacy Spotlight Partnership Program | Princeton, NJ Patch
![Manchester Biomedical Research Centre Manchester BRC researcher receives Melanoma Research Alliance and Rosetrees Trust Young Investigator Award - Manchester Biomedical Research Centre Manchester Biomedical Research Centre Manchester BRC researcher receives Melanoma Research Alliance and Rosetrees Trust Young Investigator Award - Manchester Biomedical Research Centre](https://www.manchesterbrc.nihr.ac.uk/wp-content/uploads/2021/07/Dr-Amaya-Viros-600x577.jpg)
Manchester Biomedical Research Centre Manchester BRC researcher receives Melanoma Research Alliance and Rosetrees Trust Young Investigator Award - Manchester Biomedical Research Centre
![MRF & MRA Commend the Senate Appropriations Committee for Supporting $20 Million for Defense-Funded Melanoma Research - Melanoma Research Foundation MRF & MRA Commend the Senate Appropriations Committee for Supporting $20 Million for Defense-Funded Melanoma Research - Melanoma Research Foundation](https://melanoma.org/wp-content/uploads/2019/09/MRA-MRF-logos-Facebook.png)